Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11401256
Dihydroquinolinones for medical treatment
granted -
US 11401507
Remnant tumor infiltrating lymphocytes and methods of preparing and using the same
granted -
US 11400284
Method of transcutaneous electrical spinal cord stimulation for facilitation of locomotion
granted -
US 11400161
Method of conjugating oligomeric compounds
granted -
US 11400164
Immunoconjugates targeting HER2
granted -
US 11400158
Biodegradable lipids for the delivery of active agents
granted -
US 11400108
Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signalling
granted -
US 11400104
Skeletal removal of bisphosphonates
granted -
US 11400098
Method of treating microbial infections
granted -
US 11400030
Two-paste dental curable composition
granted -
US 11400072
Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy
granted -
US 11401510
Generation of airway basal stem cells from human pluripotent stem cells
granted -
US 11400066
Methods of treatment of inflammation related conditions using pluripotent anti-inflammatory and metabolic modulators
granted -
US 11401513
Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use
granted -
US 11400063
Early administration of low-dose colchicine after myocardial infarction
granted -
US 11400052
Alcohol-resistant drug formulations
granted -
US 11399540
Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
granted -
US 11401506
Enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy
granted -
US 11401512
Engineered target specific nucleases
granted -
WO 2022158991
TRAITEMENT DE LA DOULEUR ASSOCIÉE À LA MALADIE DE PARKINSON AVEC DE L'OPICAPONE EN COMBINAISON AVEC LA LÉVODOPA
granted -
EP 4031157
BAKTERIENSTÄMME, IHRE ZUSAMMENSETZUNGEN UND IHRE VERWENDUNG ZUR BEHANDLUNG GASTROINTESTINALER ERKRANKUNGEN
granted -
IT 202100001169
GEL MUCOADESIVO BUCCALE CONTENENTE PROBIOTICI PER USO NELLA PREVENZIONE E NEL TRATTAMENTO DELLE MALATTIE PARODONTALI.
granted -
US 11396544
Bispecific anti-CD28 × anti-CD22 antibodies and uses thereof
granted -
US 11396530
Bicyclic peptide ligands and uses thereof
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.